Publications by authors named "Javier Loureiro Diaz"

Cardiac rehabilitation (CR) significantly improves cardiovascular outcomes in patients with coronary artery disease (CAD). International guidelines vary in the minimum recommended frequency of supervised exercise from 1 to 3 sessions per week. This is the first study in the Middle East and North African regions assessing the impact of 2 versus 3 days/week of supervised exercise on peak exercise capacity in patients with CAD.

View Article and Find Full Text PDF

Cardiac rehabilitation (CR) is recommended for all patients with stable angina (SA) as an effective treatment. Hemoglobin (Hgb) levels predict exercise performance and may affect symptom threshold in SA patients. A multidisciplinary CR intervention was individually tailored for a 72-year-old patient with a diagnosis of SA, low Hgb (<10 g/dL), and typical chest pain at light-to-moderate exercise (<5 metabolic equivalent task), who was stratified as at high risk for cardiac events during exercise.

View Article and Find Full Text PDF

Introduction: Cardiac implantable electronic devices (CIEDs), including pacemakers, defibrillators, and resynchronization devices, significantly enhance patient outcomes, reduce sudden cardiac death, and improve health-related quality of life. CIED implantation is associated to persistent shoulder dysfunction in a considerable number of patients one-year post-implantation. This may result in disability, diminished quality of life, work absenteeism, and negative psychological effects.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic led to a significant reduction in cardiac rehabilitation programs, with CR phase II services in Qatar stopping in March 2020.
  • A multidisciplinary team created a hybrid cardiac rehabilitation exercise program (HCRP2-EP) to continue patient care, aiming to enroll 70% of eligible patients by September 2020, which they successfully achieved.
  • The HCRP2-EP showed positive results, with 75.8% of participants experiencing a significant increase in exercise capacity and a high patient satisfaction score of 96%, indicating that the program is safe and effective for male patients with cardiovascular disease.
View Article and Find Full Text PDF